Cargando…
New Biomarkers Based on Dendritic Cells for Breast Cancer Treatment and Prognosis Diagnosis
Dendritic cells(DCs) play a protective role in the antitumor immunity of most cancers, which can be divided into conventional dendritic cells (cDCs) and plasmacytoid dendritic cells (pDCs). Most current studies are only based on either cDCs or pDCs for the study of the relationship between DCs and b...
Autores principales: | Zhao, Fanjia, Yan, Fang, Liu, Haihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963148/ https://www.ncbi.nlm.nih.gov/pubmed/36835467 http://dx.doi.org/10.3390/ijms24044058 |
Ejemplares similares
-
Autoantibodies as biomarkers for breast cancer diagnosis and prognosis
por: Yang, Ruozhu, et al.
Publicado: (2022) -
MRI as a biomarker for breast cancer diagnosis and prognosis
por: Galati, Francesca, et al.
Publicado: (2022) -
Dendritic Cells Are Associated with Prognosis and Survival in Breast Cancer
por: Szpor, Joanna, et al.
Publicado: (2021) -
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
por: Bertoli, Gloria, et al.
Publicado: (2015) -
Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review
por: Arip, Masita, et al.
Publicado: (2022)